By Peter A. McCullough
Most of the attention on COVID-19 vaccine safety has been focussed on mRNA vaccines (Pfizer, Moderna) in which there is no way of shutting off mRNA production of Spike protein. Antigen-based Novavax provides 5 mcg of Spike and no genetic code. Many have favored Novavax for this reason, yet the CDC, FDA, and NIH have been largely focussed on the genetic vaccines. Recently there were comparative data presented.
Click this link for the original source of this article.
Author: Peter A. McCullough, MD, MPH
This content is courtesy of, and owned and copyrighted by, https://petermcculloughmd.substack.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.
